RAAV2-TGF-β3 decreases collagen synthesis and deposition in the liver of experimental Hepatic fibrosis rat

Digestive Diseases and Sciences

Volumn 55, Issue 10, 2010, Pages 2821-2830

  Zhang, Yi ^a   Liu, Ping ^a   Gao, Xiaoliang ^a   Qian, Wei ^a   Xu, Keshu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Extracellular matrix; Liver fibrosis; Recombinantadenoassociated virus; Transforming growth factor 3

Indexed keywords

CARBON TETRACHLORIDE; COLLAGEN; COLLAGEN TYPE 1; ENHANCED GREEN FLUORESCENT PROTEIN; GELATINASE A; GELATINASE B; PARVOVIRUS VECTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA3; GREEN FLUORESCENT PROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; RAT; VIRUS RECOMBINANT; ADENOVIRUS; ANIMAL; BIOPSY; BIOSYNTHESIS; DISEASE MODEL; EXTRACELLULAR MATRIX; GENETICS; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

ADENOVIRIDAE; ANIMALS; BIOPSY; COLLAGEN TYPE I; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GREEN FLUORESCENT PROTEINS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA3;

EID: 77957895411     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1119-3     Document Type: Article

References (22)

1. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol. 2003;38(Suppl. 1):S38-S53.
2. Vaillant B, Chiaramonte MG, Cheever AW, Soloway PD, Wynn TA. Regulation of hepatic fibrosis and extracellular matrix genes by the the response: New insight into the role of tissue inhibitors of matrix metalloproteinases. J Immunol. 2001;167:7017-7026.
3. Albanis E, Friedman SL. Hepatic fibrosis: Pathogenesis and principles of therapy. Clin Liver Dis. 2001;5:315-334. V-VI.
4. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005; 115(2):209-218.
5. Benyon RC, Iredale JP. Is liver fibrosis reversible? Gut. 2000; 46:443-446.
6. Gressner AM, Weiskirchen R, Breitkopf K, et al. Roles of TGFbeta in hepatic fibrosis. Front Biosci. 2002;7:d793-d807.
7. Wynn TA. Fibrotic disease and the Th1/Th2 paradigm. Nat Rev Immunol. 2004;4(8):583.
8. Leask A, Abraham DJ. TGF-b signaling and the fibrotic response. FASEB J. 2004;18(7):816-827.
9. Hakvoort T, Altun V, Van Zuijlen PP, et al. Transforming growth factor-beta (1), -beta(2), -beta(3), basic fibroblast growth factor and vascular endothelial growth factor expression in keratinocytes of burn scars. Eur Cytokine Netw. 2000;11(2):233-239.
10. De Bleser PJ, Niki T, Rogiers V, Geerts A. Transforming growth factor-beta gene expression in normal and fibrotic rat liver. J Hepatol. 1997;26(4):886-893.
11. Kohama K, Nonaka K, Hosokawa R, et al. TGF-beta-3 promotes scarless repair of cleft lip in mouse fetuses. J Dent Res. 2002; 81(10):688-694.
12. Shek FW, Li KF, Mann J, et al. TGF-b3 express anti-fibrosis properties in pancreatic stellate cells. Gut. 2004;53(11):supplement A16.
13. Li Q, Zhou X, Yu J, Qian W, et al. Influence of recombinant transforming growth factor-beta3 on collagen synthesis and deposition: experiment with rat cell model of liver fibrosis. Zhonghua Yi Xue Za Zhi. 2008;88(18):1273-1278.
14. Zhou X, Yu J, Li Q, Qian W, et al. Effects of transforming growth factor-beta 3 gene transfer on type I collagen synthesis of hepatic stellate cells. Zhonghua Gan Zang Bing Za Zhi. 2008;16(1): 43-48.
15. The subordinate association of infection and parasitosis diseases, Chinese Medical Association. The preventive and therapic program of viral hepatitis. China Intern Med J. 2001;1(40):62-68.
16. Lawrence DA. Latent-TGF-b: An overview. Mol Cell Biochem. 2001;219:163-170.
17. Hosokawa R, Nonaka K, Morifuji M, et al. TGF-beta3 decreases type I collagen and scarring after labioplasty. J Dent Res. 2003;82(7):559-564.
18. Carrington LM, Albon J, Anderson I, et al. Differential regulation of key stages in early corneal wound healing by TGF-beta isoforms and their inhibitors. Invest Ophthalmol Vis Sci. 2006;47(5):1886-1894.
19. Lalani AS, Chang B, Lin J, et al. Anti-tumor efficacy of human angiostain using liver-mediated adeno-associated virus gene therapy. Mol Ther. 2004;9:56-66.
20. You H, Jia JD, Wang BE. Gene therapy in liver diseases using adeno-associated virus as a vector. Zhonghua Gan Zang Bing Za Zhi. 2005;13(8):639-640.
21. Brenner DA, Waterboer T, Choi SK, et al. New aspects of hepatic fibrosis. J Hepatol. 2000;32(1 suppl):32-38.
22. Blavier L, Lazaryev A, Groffen J, et al. TGF-beta3-induced palatogenesis requires matrix metalloproteinases. Mol Biol Cell. 2001;12(5):1457-1466.